98 related articles for article (PubMed ID: 29791117)
1. Anti-neoplastic effects of topoisomerase inhibitors in canine mammary carcinoma, melanoma, and osteosarcoma cell lines.
Ong SM; Yamamoto H; Saeki K; Tanaka Y; Yoshitake R; Nishimura R; Nakagawa T
Jpn J Vet Res; 2017 Feb; 65(1):17-28. PubMed ID: 29791117
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumour effect of metformin in canine mammary gland tumour cells.
Saeki K; Watanabe M; Tsuboi M; Sugano S; Yoshitake R; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
Vet J; 2015 Aug; 205(2):297-304. PubMed ID: 25981932
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effects of rivoceranib against canine melanoma and mammary gland tumour in vitro and in vivo mouse xenograft models.
Li Q; Kim YS; An JH; Kwon JA; Han SH; Song WJ; Youn HY
BMC Vet Res; 2021 Oct; 17(1):338. PubMed ID: 34702279
[TBL] [Abstract][Full Text] [Related]
4. Aldoxorubicin-loaded nanofibers are cytotoxic for canine mammary carcinoma and osteosarcoma cell lines in vitro: A short communication.
Stokol T; Wan C; Blakely R; Bellat V; Law B
Res Vet Sci; 2020 Feb; 128():86-89. PubMed ID: 31760317
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumour efficacy of etoposide alone and in combination with piroxicam against canine osteosarcoma in a xenograft model.
Ong SM; Saeki K; Kok MK; Tanaka Y; Choisunirachon N; Yoshitake R; Nishimura R; Nakagawa T
Res Vet Sci; 2017 Aug; 113():130-135. PubMed ID: 28957780
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic screening of a library of compounds against metastatic and non-metastatic clones of a canine mammary gland tumour cell line.
Saeki K; Watanabe M; Michishita M; Tsuboi M; Sugano S; Yoshitake R; Murai K; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
Vet J; 2015 Aug; 205(2):288-96. PubMed ID: 25975851
[TBL] [Abstract][Full Text] [Related]
7. Effect of tolfenamic acid on canine cancer cell proliferation, specificity protein (sp) transcription factors, and sp-regulated proteins in canine osteosarcoma, mammary carcinoma, and melanoma cells.
Wilson H; Chadalapaka G; Jutooru I; Sheppard S; Pfent C; Safe S
J Vet Intern Med; 2012; 26(4):977-86. PubMed ID: 22536857
[TBL] [Abstract][Full Text] [Related]
8. Identification of anti-proliferative kinase inhibitors as potential therapeutic agents to treat canine osteosarcoma.
Mauchle U; Selvarajah GT; Mol JA; Kirpensteijn J; Verheije MH
Vet J; 2015 Aug; 205(2):281-7. PubMed ID: 25190293
[TBL] [Abstract][Full Text] [Related]
9. Cellular effects of a turmeric root and rosemary leaf extract on canine neoplastic cell lines.
Levine CB; Bayle J; Biourge V; Wakshlag JJ
BMC Vet Res; 2017 Dec; 13(1):388. PubMed ID: 29237458
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of cyclooxygenase-2 related multi-drug resistance gene in melanoma and osteosarcoma cell lines by TSG-6 secreted from canine adipose-derived mesenchymal stem/stromal cells.
Yang SJ; An JH; Park SM; Lee JH; Chae HK; Lee KM; Song WJ; Youn HY
Vet Med Sci; 2021 May; 7(3):968-978. PubMed ID: 33570264
[TBL] [Abstract][Full Text] [Related]
12. Plasticity of cloned canine mammary spindle cell tumor, osteosarcoma and carcinoma cells.
Wensman H; Flama V; Pejler G; Hellmén E
Vet Pathol; 2008 Nov; 45(6):803-15. PubMed ID: 18984783
[TBL] [Abstract][Full Text] [Related]
13. The oncolytic effects of reovirus in canine solid tumor cell lines.
Igase M; Hwang CC; Coffey M; Okuda M; Noguchi S; Mizuno T
J Vet Med Sci; 2015 May; 77(5):541-8. PubMed ID: 25648933
[TBL] [Abstract][Full Text] [Related]
14. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
Jaroensong T; Endo Y; Lee SJ; Kamida A; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
Vet Comp Oncol; 2012 Dec; 10(4):274-82. PubMed ID: 22236104
[TBL] [Abstract][Full Text] [Related]
15. Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines.
Ong SM; Saeki K; Tanaka Y; Nishimura R; Nakagawa T
Vet J; 2016 Dec; 218():51-59. PubMed ID: 27938709
[TBL] [Abstract][Full Text] [Related]
16. Selective growth inhibition by suppression of F1Fo ATPase in canine malignant melanoma cell lines.
Kuroki S; Kobayashi M; Tani H; Miyamoto R; Kurita S; Tamura K; Ono K; Washizu T; Bonkobara M
J Vet Pharmacol Ther; 2017 Jan; 40(1):101-104. PubMed ID: 27292541
[TBL] [Abstract][Full Text] [Related]
17. Calotropis procera (Aiton) Dryand (Apocynaceae) as an anti-cancer agent against canine mammary tumor and osteosarcoma cells.
Rabelo AC; Borghesi J; Carreira ACO; Hayashi RG; Bessa F; Barreto RDSN; da Costa RP; Cantanhede Filho AJ; Carneiro FJC; Miglino MA
Res Vet Sci; 2021 Sep; 138():79-89. PubMed ID: 34119813
[TBL] [Abstract][Full Text] [Related]
18. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
[TBL] [Abstract][Full Text] [Related]
19. The proteasome inhibitor bortezomib inhibits the growth of canine malignant melanoma cells in vitro and in vivo.
Ito K; Kobayashi M; Kuroki S; Sasaki Y; Iwata T; Mori K; Kuroki T; Ozawa Y; Tetsuka M; Nakagawa T; Hiroi T; Yamamoto H; Ono K; Washizu T; Bonkobara M
Vet J; 2013 Dec; 198(3):577-82. PubMed ID: 24035468
[TBL] [Abstract][Full Text] [Related]
20. Hexadecylphosphocholine causes rapid cell death in canine mammary tumour cells.
Duijsings D; Houweling M; Vaandrager AB; Mol JA; Teerds KJ
Eur J Pharmacol; 2004 Oct; 502(3):185-93. PubMed ID: 15476744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
